BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual ...

In key Trump tariff news over the weekend, President Donald Trump's 10% baseline tariff on all imports took effect while Treasury Secretary Scott Bessent rejected the idea that Trump tariffs would ...

Phase 3 trial results for rolapitant, a novel NK-1 receptor antagonist, in the prevention of chemotherapy-induced nausea and vomiting (CINV) in subjects receiving highly emetogenic chemotherapy (HEC).

President Trump’s 10% global tariffs went into effect at 12:01 a.m. Saturday, Eastern time, subjecting virtually every nation and the vast majority of imported products to new duties. The 10% tariff ...

– New safety and tolerability data show high treatment compliance with apraglutide, low incidence of injection site reactions and adverse events associated with GI tolerability – – Findings reinforce ...